Enlivex Therapeutics Ltd.

7 clinical trials · Sponsor

Record	Firm	Date
Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis (NCT07580716)	Enlivex Therapeutics Ltd.	2026-05-01
Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis (NCT06522035)	Enlivex Therapeutics Ltd.	2024-08-01
Study of Intra-articular Allocetra in Knee Osteoarthritis (NCT06233474)	Enlivex Therapeutics Ltd.	2024-01-26
Study Evaluating Safety and Tolerability of Allocetra-OTS in Patients With COVID-19 (NCT04659304)	Enlivex Therapeutics Ltd.	2021-12-01
A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS) (NCT04922957)	Enlivex Therapeutics Ltd.	2021-09-01
A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients (NCT04612413)	Enlivex Therapeutics Ltd.	2020-11-30
Prevention of Sepsis-related Organ Dysfunction With Allocetra-OTS (NCT03925857)	Enlivex Therapeutics Ltd.	2019-01-27

Every clearance here is in the API, with alerts when new ones post.